FrancophonIA/ELRC3.0 huggingface dataset:
English: When mixed with Canigen vaccines containing canine parainfluenza virus strain Cornell at annual revaccination, it has been established that there is no interference with the anamnestic response induced by the injectable canine parainfluenza virus component.
Croatian: Pri godišnjoj revakcinaciji kombiniranim cjepivima koja sadrže virus parainfluence, soj Cornell dokazano je da nema interferencije u anamnestičkom odgovoru izazvanom komponentom virusa pseće parainfluence.
English: In very rare cases, clinical signs of immune-mediated haemolytic anaemia, immune-mediated thrombocytopenia, or immune-mediated polyarthritis have been reported.
Croatian: U vrlo rijetkim slučajevima prijavljeni su klinički znakovi imunološki posredovane hemolitičke anemije, imuno posredovane trombocitopenije ili imuno posredovanog poliartritisa.
English: For example, local swelling, which can be up to 5 cm in diameter and which may take over 5 weeks to completely disappear, may be observed at the site of injection.
Croatian: Na primjer, na mjestu aplikacije cjepiva može se pojaviti oteklina, promjera do 5 cm, a do njenog potpunog nestanka može proći više od 5 tjedana.
English: EXPIRY DATE EXP {month/year} Once broached, use within 10 hours
Croatian: EXP {mjesec/godina} Jednom otvoreno, primijeniti unutar 10 sati.
English: When mixed with these Canigen vaccines, the demonstrated safety and efficacy claims for Canigen L4 are no different from those described for Canigen L4 alone.
Croatian: Kod kombinirane upotrebe Caningen cjepiva dokazana neškodljivost i učinkovitost za Caningen L4 nije različita od one opisane kod samog Caningena L4.
English: 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Croatian: 6.6 Posebne mjere predostrožnosti za odlaganje neupotrebljenog veterinarsko medicinskog proizvoda ili otpadnih materijala dobivenih primjenom tih proizvoda
English: Shelf life after reconstitution of Canigen vaccines according to directions: 45 mins.
Croatian: Rok valjanosti cjepiva Canigen poslije rekonstitucije: 45 minuta.
English: Bury St. Edmunds, Suffolk, IP30 9UP, Tel: + 44 (0) 1359 243243
Croatian: Edmunds, Suffolk, IP30 9UP, Tel: + 44 (0) 1359 243243
English: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Croatian: Stoga odluku o primjeni ovog cjepiva, prije, odnosno poslije primjene bilo kojeg drugog veterinarskomedicinskog proizvoda treba donositi od slučaja do slučaja.
English: A mild and transient increase in body temperature (≤ 1°C) has been observed very commonly in clinical studies for a few days after vaccination, with some pups showing less activity and/or a reduced appetite.
Croatian: Prolazno, blago povećanje tjelesne temperature (≤ 1°C) često se pojavljuje nekoliko dana nakon cijepljenja uz smanjenu aktivnost i/ili smanjen apetit kod nekih štenaca.
English: A small transient swelling at the site of injection (≤ 4 cm), which can occasionally be firm and painful on palpation, has been observed very commonly in clinical studies.
Croatian: Prolazna oteklina (≤ 4 cm), koja se često pojavljivala u kliničkim ispitivanjima, ponekad može biti tvrda i bolna na dodir.
English: Active substances:
Croatian: Proizvođač djelatne tvari:
English: Luxembourg/Luxemburg: VIRBAC,
Croatian: Luxembourg/Luxemburg:
English: Plastic box with 10 or 50 vials of 1 ml (1 dose).
Croatian: Plastična kutija s 10 ili 50 bočica od 1 ml (1 doza).
English: PACKAGE LEAFLET: Canigen L4 suspension for injection for dogs
Croatian: Canigen L4 suspenzija za injekciju za pse
English: MARKETING AUTHORISATION NUMBER(S) EU/2/15/183/001-003
Croatian: EU/2/15/183/001-003
English: - L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001)
Croatian: - L. interrogans, serogrupa Icterohaemorrhagiae, serovar Copenhageni (soj Ic-02-001)
English: - L. interrogans serogroup Australis serovar Bratislava (strain As-05-073)
Croatian: - L. interrogans, serogrupa Australis, serovar Bratislava (soj As-05-073)
English: Inactivated Leptospira strains: - L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12
Croatian: Inaktivirani sojevi Leptospira: - L. interrogans, serogrupa Canicola, serovar Portland-vere (soj Ca-12
English: Such reactions may evolve to a more severe condition (anaphylaxis), which may be life-threatening.
Croatian: Takve reakcije mogu se pojaviti kao prolazna akutna reakcija preosjetljivosti, koja može evoluirati u ozbiljnije stanje
English: 10 ml (10 doses)
Croatian: 1 ml (1 doza) 10 ml (10 doza)
English: Incompatibilities: Do not mix with any other veterinary medicinal products except the above mentioned vaccines.
Croatian: Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom osim s gore navedenim vakcinama.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Canigen L4 suspension for injection for dogs
Croatian: Canigen L4, suspenzija za injekciju za pse
English: VIRBAC France, 13ème rue - L.I.D., FR-06517 Carros, service-conso@virbac.fr
Croatian: FR-06517 Carros, service-conso@virbac.fr
English: In very rare cases a transient acute hypersensitivity reaction may occur.
Croatian: Takve reakcije mogu se pojaviti kao prolazna akutna reakcija preosjetljivosti koja može evoluirati u ozbiljnije stanje
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs
Croatian: UVJETI ILI OGRANIČENJA U POGLEDU OPSKRBE I PRIMJENE
English: In vitro and in vivo data in non-target species suggest that the vaccine may provide a degree of cross-protection against L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa.
Croatian: In vitro i in vivo podaci ukazuju da cjepivo, u neciljnih vrsta životinja, može pružiti određeni stupanj unakrižne zaštite protiv L. interrogans, serogrupa Icterohaemorrhagiae, serovar Icterohaemorrhagiae i L. kirschneri, serogrupa Grippotyphosa, serovar Grippotyphosa.
English: 1 ml and 10 ml vial
Croatian: Bočice od 1 ml i 10 ml
English: For active immunisation of dogs against: - L. interrogans serogroup Canicola serovar Canicola to reduce infection and urinary excretion - L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni to reduce infection and urinary excretion - L. interrogans serogroup Australis serovar Bratislava to reduce infection - L. kirschneri serogroup Grippotyphosa serovar Bananal/Lianguang to reduce infection and urinary excretion
Croatian: Za aktivnu imunizaciju pasa protiv: - L. interrogans, serogrupa Canicola, serovar Canicola za smanjenje infekcije i izlučivanja putem urina, - L. interrogans, serogoupa Icterohaemorrhagiae, serovar Copenhagen za smanjenje infekcije i izlučivanja putem urina, - L. interrogans, serogrupa Australis, serovar Bratislava za smanjenje infekcije, - L. kirschneri, serogrupa Grippotyphosa, serovar Bananal/Lianguang za smanjenje infekcije i izlučivanja putem urina.
English: Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with vaccines of the Canigen series from the same marketing authorisation holder (or national subsidiary) containing Bordetella bronchiseptica strain B-C2 and/or canine parainfluenza virus strain Cornell components for intranasal administration where authorised.
Croatian: Dostupni podaci o neškodljivosti i djelotvornosti dokazuju, da ovo cjepivo smije biti primijenjeno istoga dana, ali ne pomiješano, s cjepivima iz serije Canigen, istog nositelja odobrenja (ili lokalne podružnice) koja sadrže komponente Bordetella bronchiseptica, soj B-C2 i/ili parainfluenca virus pasa, soj Cornell, za intranazalnu primjenu, ukoliko je odobreno.
English: Store in a refrigerator (2 °C - 8 °C).
Croatian: 6.4 Posebne mjere predostrožnosti za čuvanje Čuvati u hladnjaku (2 C - 8°C).
English: Pack sizes:
Croatian: Pakovanja:
English: No adverse reactions other than those mentioned in section 4.6 were observed after the administration of a double dose of vaccine.
Croatian: Nakon primjene dvostruke doze nisu uočene neželjene pojave osim onih navedenih u odjeljku 4.6. Ipak, ove reakcije mogu biti izraženije i/ili trajati dulje.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Canigen L4
Croatian: Canigen L4
English: Plastic box with 10, or 50 vials of 1 ml Cardboard box with 1 vial of 10 ml
Croatian: PODACI NA VANJSKOM PAKOVANJU KUTIJA Plastična kutija s 10 ili 50 bočica od 1ml
English: Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with vaccines of the Canigen series from the same marketing authorisation holder (or national subsidiary) containing canine distemper virus strain Onderstepoort, canine adenovirus type 2 strain Manhattan LPV3, canine parvovirus strain 154 and/or canine parainfluenza virus strain Cornell components for subcutaneous administration where authorised.
Croatian: Dostupni podaci o neškodljivosti i djelotvornosti dokazuju da se ovo cjepivo smije pomiješati i upotrijebiti s cjepivima iz serije Canigen, istog nositelja odobrenja (ili lokalne podružnice) koja sadrže komponente virus štenećaka, soj Onderstepoort, psećeg adenovirusa tip 2, soj Manhattan LPV3, psećeg parvovirusa, soj 154 i/ili psećeg virusa parainfluence, soj Cornell, za subkutanu primjenu, ukoliko je odobreno.
English: The product information of the relevant Canigen vaccines should be consulted before administration of the mixed product.
Croatian: Prije aplikacije Caningen L4 u kombinaciji s odgovarajućim Caningen cjepivima potrebno je pročitati uputu o proizvodu s kojim se cjepivo miješa.
English: For simultaneous use with Canigen vaccines where authorised: 1 dose of a Canigen vaccine from the same marketing authorisation holder (or national subsidiary) containing canine distemper virus strain Onderstepoort, canine adenovirus type 2 strain Manhattan LPV3, canine parvovirus strain 154 and/or canine parainfluenza virus strain Cornell components should be reconstituted with 1 dose (1 ml) of Canigen L4.
Croatian: Onderstepoort, psećeg adenovirusa tip 2, soj Manhattan LPV3, psećeg parvovirusa, soj 154 i/ili virusa pseće parainfluence, soj Cornell treba otopiti s 1 dozom (1 ml) Canigen L4.
English: No adverse reactions other than those mentioned in section 6 were observed after the administration of a double dose of vaccine.
Croatian: Predoziranje (simptomi, hitni postupci, antidoti): Nakon primjene dvostruke doze nisu uočene neželjene pojave osim onih navedenih u odjeljku 6.
English: For simultaneous use with Canigen vaccines where authorised: 1 dose of a Canigen vaccine from the same marketing authorisation holder (or national subsidiary) containing canine distemper virus strain Onderstepoort, canine adenovirus type 2 strain Manhattan LPV3, canine parvovirus strain 154, and/or canine parainfluenza virus strain Cornell components should be reconstituted with 1 dose (1 ml) of Canigen L4.
Croatian: Onderstepoort, psećeg adenovirusa tip 2, soj Manhattan LPV3, psećeg parvovirusa, soj 154, i/ili virus pseće parainfluence, soj Cornell treba otopiti s 1 dozom (1 ml) Nobivac L4.
English: FR-06516 Carros, France/ Frankrijk/Frankreich Tel: + 33 (0) 4 92 08 73 00
Croatian: 1ère avenue 2065 m - L.I.D., FR-06516 Carros, France/ Frankrijk/Frankreich Tel: + 33 (0) 4 92 08 73 00
English: Special precautions for each target species: Vaccinate healthy animals only.
Croatian: Posebna upozorenja za primjenu na životinjama:
English: The first three doses are given at two-week intervals.
Croatian: Prve tri doze daju se u dvotjednim intervalima.
English: Patients should therefore be observed for several hours after at least the first two infusions.
Croatian: Bolesnike stoga treba promatrati nekoliko sati, barem nakon prvih dviju infuzija.
English: After this, Benlysta is given once every four weeks.
Croatian: Nakon toga, Benlysta se daje jedanput svaka četiri tjedna.
English: Infections may be more likely in younger children.
Croatian: Pojava infekcija može biti vjerojatnije u manje djece.
English: The Agency also noted the lack of effective alternative treatments for patients who have already tried standard treatments.
Croatian: Agencija je također napomenula da ne postoje učinkovita alternativna liječenja za bolesnike koji su već isprobali standardno liječenje.
English: Further information on Benlysta can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/benlysta.
Croatian: Više informacija o lijeku Benlysta dostupno je na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/benlysta.
English: Benlysta is given to patients whose disease is still highly active despite standard treatment.
Croatian: Benlysta se daje bolesnicima u kojih je bolest i dalje vrlo aktivna unatoč standardnom liječenju.
English: What is Benlysta and what is it used for?
Croatian: Što je Benlysta i za što se koristi?
English: Benlysta received a marketing authorisation valid throughout the European Union on 13 July 2011.
Croatian: Lijek Benlysta dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 13. srpnja 2011.
English: All infusions with Benlysta, and the first injection under the skin, should be given in a place where these reactions can be managed immediately if they occur.
Croatian: Sve infuzije lijeka Benlysta te prvu injekciju pod kožu potrebno je dati na mjestu gdje se takve reakcije mogu odmah ublažiti ako se pojave.
English: What measures are being taken to ensure the safe and effective use of Benlysta?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Benlysta?
English: Usually, B lymphocytes produce antibodies which help to fight infections.
Croatian: B limfociti obično proizvode protutijela koja pomažu u borbi protiv infekcija.
English: Results from a main study involving 93 children aged 5 to 17 years with active SLE showed that Benlysta was distributed in the body in a similar way as in adults and could be expected to have similar benefits.
Croatian: Rezultati glavnog ispitivanja, kojim je bilo obuhvaćeno 93 djece u dobi od 5 do 17 godina s aktivnim SLE-om, pokazali su da se Benlysta raspoređuje u tijelu na sličan način kao u odraslih osoba te da se mogu očekivati slične koristi.
English: Side effects reported with Benlysta are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Benlysta pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: The company that markets Benlysta will provide further information on the safety of the medicine from a study and from a register of patients being followed up long-term.
Croatian: Tvrtka koja stavlja lijek Benlysta u promet dostavit će dodatne informacije o sigurnosti lijeka iz ispitivanja i iz registra dugoročnog praćenja bolesnika.
English: The European Medicines Agency decided that Benlysta's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi od lijeka Benlysta nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u EU-u.
English: Other information about Benlysta
Croatian: Ostale informacije o lijeku Benlysta
English: SLE can affect almost any organ in the body, and is thought to involve a type of white blood cell called B lymphocytes.
Croatian: SLE može zahvatiti gotovo svaki organ u tijelu, a smatra se da je bolest posredovana vrstom bijelih krvnih stanica naziva B limfociti.
English: The medicine may cause infusion and hypersensitivity reactions as well as infections, but is generally well tolerated.
Croatian: Lijek može uzrokovati reakcije na infuziju ili reakcije preosjetljivosti te infekcije, ali se općenito dobro podnosi.
English: When Benlysta is given as an infusion into a vein, the recommended dose is 10 mg per kilogram body weight given over one hour.
Croatian: Kada se Benlysta primjenjuje infuzijom u venu, preporučena doza iznosi 10 mg po kilogramu tjelesne težine i daje se tijekom jednog sata.
English: What are the risks associated with Benlysta?
Croatian: Koji su rizici povezani s lijekom Benlysta?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Benlysta have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Benlysta nalaze se također u sažetku opisa svojstava i u uputi o lijeku.
English: Why is Benlysta authorised in the EU?
Croatian: Zašto je lijek Benlysta odobren u EU-u?
English: Benlysta can only be obtained with a prescription and treatment should only be started and supervised by a doctor who has experience in the diagnosis and treatment of SLE.
Croatian: Benlysta se izdaje samo na recept, a liječenje smije započeti i nadzirati isključivo liječnik iskusan u dijagnosticiranju i liječenju SLE-a.
English: The doctor may interrupt or stop treatment if the patient develops reactions linked to the infusion (such as rash, itchiness and difficulty breathing) or hypersensitivity (allergic) reactions which may be severe and life-threatening and can develop several hours after Benlysta is given.
Croatian: Liječnik može prekinuti ili obustaviti liječenje ako se u bolesnika pojave reakcije na infuziju (kao što su osip, svrbež i otežano disanje) ili reakcije preosjetljivosti (alergijske reakcije) koje mogu biti teške i opasne po život, a mogu se pojaviti nekoliko sati nakon primjene lijeka Benlysta.
English: As for all medicines, data on the use of Benlysta are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Benlysta kontinuirano se prate.
English: Benlysta is a medicine used as an add-on treatment in patients aged 5 years and older with systemic lupus erythematosus (SLE), a disease in which the immune system (the body's natural defences) attacks normal cells and tissues, causing inflammation and organ damage.
Croatian: Benlysta je lijek koji se koristi kao dodatna terapija u bolesnika u dobi od 5 godina i starijih sa sistemskim eritemskim lupusom (SLE), bolesti pri kojoj imunosni sustav (prirodna obrana tijela) napada zdrave stanice i tkiva te izaziva upalu i oštećenja organa.
English: An overview of Benlysta and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Benlysta i zašto je odobren u EU-u
English: The most common side effects with Benlysta (which may affect more than 1 in 10 people) are bacterial infections, such as bronchitis (infection in the lungs) and infection of the urinary tract (structures that produce or carry urine), diarrhoea and nausea (feeling sick).
Croatian: Najčešće nuspojave lijeka Benlysta (koje se mogu pojaviti u više od 1 na 10 osoba) jesu bakterijske infekcije kao što su bronhitis (infekcija dišnih putova u plućima) i infekcije urinarnog trakta (organa koji proizvode ili prenose urin), proljev i mučnina.
English: In SLE, some of these antibodies attack the body's own cells and organs instead (autoantibodies).
Croatian: Međutim, u bolesnika sa SLE-om neka od tih protutijela napadaju stanice i organe samog tijela (autoprotutijela).
English: By blocking the action of BLyS, belimumab reduces the life span of B lymphocytes, thereby reducing the inflammation and organ damage that occur in SLE.
Croatian: Blokiranjem djelovanja BLyS-a belimumab smanjuje životni vijek B limfocita i time umanjuje upalu i oštećenja organa do kojih dolazi u bolesnika sa SLE-om.
English: Another study involved 836 adult patients with active SLE, who received add-on Benlysta as an injection under the skin once a week for a year.
Croatian: Drugim ispitivanjem bilo je obuhvaćeno 836 odraslih bolesnika s aktivnim SLE-om koji su tijekom godinu dana jedanput tjedno primali lijek Benlysta kao dodatnu terapiju u obliku injekcije pod kožu.
English: Benlysta contains the active substance belimumab.
Croatian: Benlysta sadrži djelatnu tvar belimumab.
English: For more information about using Benlysta, see the package leaflet or contact your doctor or pharmacist.
Croatian: Za više informacija o primjeni lijeka Benlysta pročitajte uputu o lijeku odnosno obratite se liječniku ili ljekarniku.
English: Patients may inject Benlysta themselves once they have been properly trained, if the doctor considers this appropriate.
Croatian: Nakon pravilne obuke bolesnici mogu sami sebi ubrizgavati lijek Benlysta ako to liječnik smatra primjerenim.
English: The Agency considered that Benlysta, used as an add-on treatment, reduced disease activity in SLE.
Croatian: Agencija je zaključila da se primjenom lijeka Benlysta kao dodatne terapije smanjuje aktivnost SLE-a.
English: In adults, Benlysta can also be given as a 200-mg injection under the skin, once a week.
Croatian: U odraslih osoba Benlysta se može davati i jedanput tjedno u obliku injekcije pod kožu od 200 mg.
English: The active substance in Benlysta, belimumab, is a monoclonal antibody, a protein that has been designed to attach to and block a protein called BLyS which helps B lymphocytes to live longer.
Croatian: Djelatna tvar u lijeku Benlysta, belimumab, monoklonsko je protutijelo namijenjeno za vezanje na protein naziva BLyS, koji omogućuje B limfocitima da žive dulje, i njegovo blokiranje.
English: Benlysta is available as a powder (120 mg and 400 mg) that is made up into a solution for infusion (drip) into a vein; it is also available as a pre-filled pen and pre-filled syringe (200 mg) for injection under the skin.
Croatian: Lijek Benlysta dostupan je kao prašak (120 mg i 400 mg) od kojeg se priprema otopina za infuziju (ukapavanje) u venu.
English: What benefits of Benlysta have been shown in studies?
Croatian: Koje su koristi lijeka Benlysta utvrđene u ispitivanjima?
English: For the full list of side effects and restrictions of Benlysta, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja povezanih s primjenom lijeka Benlysta potražite u uputi o lijeku.
English: In the second study, disease activity decreased in 58% of patients treated with Benlysta, compared with 44% of patients who were given placebo.
Croatian: U drugom ispitivanju aktivnost bolesti smanjila se u 58 % bolesnika liječenih lijekom Benlysta, u usporedbi s 44 % bolesnika koji su primali placebo.
English: The study showed that disease activity decreased in 61% of patients treated with Benlysta, compared with 48% of patients given placebo.
Croatian: U tom se ispitivanju pokazalo da se aktivnost bolesti smanjila u 61 % bolesnika liječenih lijekom Benlysta, u usporedbi s 48 % bolesnika koji su primali placebo.
English: In the first study, disease activity decreased in 43% of patients treated with Benlysta, compared with 34% of patients who were given placebo.
Croatian: U prvom ispitivanju aktivnost bolesti smanjila se u 43 % bolesnika liječenih lijekom Benlysta, u usporedbi s 34 % bolesnika koji su dobivali placebo.
English: How does Benlysta work?
Croatian: Kako djeluje Benlysta?
English: Benlysta given by infusion was shown to be more effective than placebo (a dummy treatment) in reducing disease activity when used as an add-on treatment for SLE in two main studies involving 1,693 adult patients with active SLE.
Croatian: U dvama glavnim ispitivanjima, kojima su bila obuhvaćena 1 693 odrasla bolesnika s aktivnim SLE-om, lijek Benlysta primijenjen infuzijom pokazao se djelotvornijim od placeba (prividnog liječenja) u smanjivanju aktivnosti bolesti kada se primjenjivao kao dodatna terapija za SLE.
English: How is Benlysta used?
Croatian: Kako se Benlysta primjenjuje?
English: Do not use on canaries.
Croatian: Ne koristiti na kanarincima.
English: For easy application the dog should be standing.
Croatian: Za lakšu aplikaciju pas bi trebao stajati.
English: In the study these reactions were common (seen in 2 of 106 treated dogs).
Croatian: U studijama te reakcije su česte (uočene u 2 od 106 tretiranih pasa).
English: Imidacloprid is toxic for birds, especially canaries.
Croatian: Imidakloprid je toksičan za ptice, pogotovo kanarince.
English: Do not allow recently treated animals to groom each other.
Croatian: Nemojte dozvoliti da se nedavno tretirane životinje međusobno ližu.
English: for cats
Croatian: Za mačke